TY  - CHAP
M1  - Book, Section
TI  - Vasculitis Further Reading
A1  - Langford, Carol A.
A1  - Fauci, Anthony S.
A2  - Jameson, J. Larry
A2  - Fauci, Anthony S.
A2  - Kasper, Dennis L.
A2  - Hauser, Stephen L.
A2  - Longo, Dan L.
A2  - Loscalzo, Joseph
PY  - 2018
T2  - Harrison's Principles of Internal Medicine, 20e
AB  - ButtgereitF  et  al:  Polymyalgia  rheumatica  and  giant  cell  arteritis:  A  systematic  review.  JAMA  315:2442,  2016.[PubMed:  ]FauciAS  et  al:  Wegener’s  granulomatosis:  Prospective  clinical  and  therapeutic  experience  with  85  patients  for  21  years.  Ann  Intern  Med  98:76,  1983.[PubMed:  ]FinkielmanJD  et  al:  Antiproteinase  3  antineutrophil  cytoplasmic  antibodies  and  disease  activity  in  Wegener  granulomatosis.  Ann  Intern  Med  147:611,  2007.[PubMed:  ]GuillevinL  et  al:  Churg-Strauss  syndrome.  Clinical  study  and  long-term  follow-up  of  96  patients.  Medicine  (Baltimore)  78:26,  1999.[PubMed:  ]HoffmanGS  et  al:  Wegener  granulomatosis:  An  analysis  of  158  patients.  Ann  Intern  Med  16:488,  1992.JayneD  et  al:  A  randomized  trial  of  maintenance  therapy  for  vasculitis  associated  with  antineutrophil  cytoplasmic  autoantibodies.  N  Engl  J  Med  349:36,  2003.[PubMed:  ]KerrGS  et  al:  Takayasu  arteritis.  Ann  Intern  Med  120:919,  1994.[PubMed:  ]LangfordCA  et  al:  A  randomized,  double-blind  trial  of  abatacept  (CTLA-4Ig)  for  the  treatment  of  giant  cell  arteritis.  Arthritis  Rheumatol  69:837,  2017.[PubMed:  ]LangfordCA  et  al:  A  randomized,  double-blind  trial  of  abatacept  (CTLA-4Ig)  for  the  treatment  of  Takayasu  arteritis.  Arthritis  Rheumatol  69:846,  2017.[PubMed:  ]PagnouxC  et  al:  Clinical  features  and  outcomes  in  348  patients  with  polyarteritis  nodosa:  A  systematic  retrospective  study  of  patients  diagnosed  between  1963  and  2005  and  entered  into  the  French  Vasculitis  Study  Group  Database.  Arthritis  Rheum  62:616,  2010.[PubMed:  ]StoneJH  et  al:  Rituximab  versus  cyclophosphamide  for  ANCA-associated  vasculitis.  N  Engl  J  Med  363:221,  2010.[PubMed:  ]StoneJH  et  al:  Trial  of  tocilizumab  in  giant-cell  arteritis.  N  Engl  J  Med  377:317,  2017.[PubMed:  ]WechslerME  et  al:  Mepolizumab  or  placebo  for  eosinophilic  granulomatosis  with  polyangiitis.  N  Engl  J  Med  376:1921,  2017.[PubMed:  ]WeyandCM,  GoronzyJJ:  Clinical  practice.  Giant-cell  arteritis  and  polymyalgia  rheumatica.  N  Engl  J  Med  371:50,  2014.[PubMed:  ]  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1178487758
ER  -